6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
14m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
46m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
47m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
47m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
47m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Marker Therapeutics Inc (NASDAQ:MRKR) — investor relations, events, news, and company updates on 6ix.

Latest News

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology

Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer

Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Financials

Revenue

$3.55 M

Market Cap

$18.24 M

EPS

-0.79

Community Chat

Ask AI